FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to medicine and pharmaceutical industry, in particular, to anti-tuberculosis pharmaceutical compositions. Claimed composition includes as active substance therapeutically effective amount of isonicotinic acid hydrazide 4-aminosalicylate and target additives. Target additives represent lactose, silicon dioxide colloidal, talc, starch, salt of stearinic acid. Pharmaceutical composition is made in form of tablets, covered by coating. Coating contains "Opadry II" by company Colorcon or composition, which consists of polyvinyl alcohol, titanium dioxide, talc, polyethylene glycol and acceptable dyes. Anti-tuberculosis medication based on of isonicotinic acid hydrazide 4-aminosalicylate has 2 year shelf life.
EFFECT: obtaining anti-tuberculosis pharmaceutical composition.
6 cl, 1 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
COMBINED ANTITUBERCULOUS PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2436580C1 |
PHARMACEUTICAL ANTI-TUBERCULOSIS COMBINED COMPOSITION | 2009 |
|
RU2424808C2 |
COMPOSITE FORMULATION WITH ANTITUBERCULOUS ACTIVITY | 2003 |
|
RU2247560C1 |
PHARMACEUTICAL ANTI-TUBERCULOSIS COMBINED COMPOSITION | 2011 |
|
RU2478389C2 |
COMBINED ANTITUBERCULOUS PHARMACEUTICAL COMPOSITION | 2008 |
|
RU2417087C2 |
ANTITUBERCULOUS AGENT | 2003 |
|
RU2247559C1 |
COMBINED ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION | 2009 |
|
RU2422145C2 |
ANTITUBERCULOUS DRUG AND METHOD OF TREATING | 2010 |
|
RU2449797C1 |
COMBINED ANTITUBERCULOUS COMPOSITION | 2009 |
|
RU2413517C1 |
COMBINED ANTI-TUBERCULOSIS PREPARATION | 2007 |
|
RU2354378C1 |
Authors
Dates
2011-06-10—Published
2009-10-23—Filed